<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "3: forwardlooking", fill: "#fd0e35"},
{source: "3: forwardlooking", target: "3: conjunction with", fill: "#fd0e35"},
{source: "3: conjunction with", target: "3: consolidated financial", fill: "#fd0e35"},
{source: "3: consolidated financial", target: "3: consolidated financial statements", fill: "#fd0e35"},
{source: "3: consolidated financial statements", target: "3: risk factors set forth", fill: "#fd0e35"},
{source: "3: forwardlooking", target: "9: incurred net losses", fill: "#da1d81"},
{source: "9: incurred net losses", target: "9: each year since", fill: "#da1d81"},
{source: "9: each year since", target: "9: organization", fill: "#da1d81"},
{source: "9: organization", target: "9: accumulated deficit at", fill: "#da1d81"},
{source: "9: accumulated deficit at", target: "9: December ", fill: "#da1d81"},
{source: "9: incurred net losses", target: "15: larger companies", fill: "#0fc0fc"},
{source: "15: larger companies", target: "15: greater resources than", fill: "#0fc0fc"},
{source: "15: greater resources than", target: "15: operations", fill: "#0fc0fc"},
{source: "15: operations", target: "15: discount retailers such as", fill: "#0fc0fc"},
{source: "15: discount retailers such as", target: "15: Costco Wholesale Corporation ", fill: "#0fc0fc"},
{source: "15: Costco Wholesale Corporation ", target: "15: competitive threat", fill: "#0fc0fc"},
{source: "15: larger companies", target: "18: HearUSA ", fill: "#e5b73b"},
{source: "18: HearUSA ", target: "18: aid manufacturer", fill: "#e5b73b"},
{source: "18: HearUSA ", target: "28: existing agreements", fill: "#6f4e37"},
{source: "28: existing agreements", target: "28: enter into new", fill: "#6f4e37"},
{source: "28: enter into new", target: "28: agreements with health insurance", fill: "#6f4e37"},
{source: "28: agreements with health insurance", target: "28: managed care organizations which may", fill: "#6f4e37"},
{source: "28: managed care organizations which may", target: "28: reduced revenues", fill: "#6f4e37"},
{source: "28: existing agreements", target: "30: agreements", fill: "#5a4fcf"},
{source: "30: agreements", target: "30: renegotiated annually", fill: "#5a4fcf"},
{source: "30: renegotiated annually", target: "30: agreements may", fill: "#5a4fcf"},
{source: "30: agreements may", target: "30: terminated by either", fill: "#5a4fcf"},
{source: "30: agreements", target: "31: no certainty", fill: "#6e7f80"},
{source: "31: no certainty", target: "31: agreements on", fill: "#6e7f80"},
{source: "31: no certainty", target: "56: common stock", fill: "#e30022"},
{source: "56: common stock", target: "56: could decline", fill: "#e30022"},
{source: "56: common stock", target: "61: HearUSA ", fill: "#480607"},
{source: "61: HearUSA ", target: "61: common stock on", fill: "#480607"},
{source: "61: common stock on", target: "61: difficult", fill: "#480607"},
{source: "61: difficult", target: "61: stockholders", fill: "#480607"},
{source: "61: stockholders", target: "61: quotations as", fill: "#480607"},
{source: "61: quotations as", target: "61: HearUSA ", fill: "#480607"},
{source: "61: HearUSA ", target: "START_HERE", fill: "#480607"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Yield position</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Reject</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Consolidation_(business)">Consolidation (business)</a></td>
      <td>In business, consolidation or amalgamation is the merger and acquisition of many smaller companies into a few much larger ones. In the context of financial accounting, consolidation refers to the aggregation of financial statements of a group company as consolidated financial statements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Equity_(finance)">Equity (finance)</a></td>
      <td>In finance, equity is ownership of assets that may have debts or other liabilities attached to them. Equity is measured for accounting purposes by subtracting liabilities from the value of the assets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_(mathematics)">Operation (mathematics)</a></td>
      <td>In mathematics, an operation is a function which takes zero or more input values (called operands) to a well-defined output value. The number of operands (also known as arguments) is the arity of the operation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/WS_Audiology">WS Audiology</a></td>
      <td>WS Audiology (formerly Sivantos Group and Widex) is a privately-owned manufacturer of hearing aids with headquarters in Denmark and Singapore with roots going back to 1878 and Siemens AG. The current company was created following the 2019 merger of Sivantos Group and Widex. Prior to that, Sivantos was spun off from Siemens after Siemens AG sold the company to EQT and Santo Holding in 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Widex">Widex</a></td>
      <td>Widex A/S is the world’s sixth largest hearing aid manufacturer. In close collaboration with international audiological researchers and specialists, the company has developed a wide range of digital hearing aid.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Paul_A._Brown">Paul A. Brown</a></td>
      <td>Paul Eugene Brown (September 7, 1908 – August 5, 1991) was an American football coach and executive in the All-America Football Conference (AAFC) and National Football League (NFL). Brown was both the co-founder and first coach of the Cleveland Browns, a team named after him, and later played a role in founding the Cincinnati Bengals.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Horton_Hears_a_Who!_(film)">Horton Hears a Who! (film)</a></td>
      <td>Horton Hears a Who! (also known as Dr.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Do_Nothing_till_You_Hear_from_Me">Do Nothing till You Hear from Me</a></td>
      <td>"Do Nothing till You Hear from Me" (also written as "Do Nothin' Til You Hear from Me") is a song with music by Duke Ellington and lyrics by Bob Russell. It originated as a 1940 instrumental ("Concerto for Cootie") that was designed to highlight the playing of Ellington's lead trumpeter, Cootie Williams.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Horton_Hears_a_Who!">Horton Hears a Who!</a></td>
      <td>Horton Hears a Who! is a children's book written and illustrated by Theodor Seuss Geisel under the pen name Dr.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Hear_'n_Aid">Hear 'n Aid</a></td>
      <td>A hearing aid is a device designed to improve hearing by making sound audible to a person with hearing loss. Hearing aids are classified as medical devices in most countries, and regulated by the respective regulations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Prenuptial_agreement">Prenuptial agreement</a></td>
      <td>A prenuptial agreement, antenuptial agreement, or premarital agreement (commonly referred to as a prenup), is a written contract entered into by a couple prior to marriage or a civil union that enables them to select and control many of the legal rights they acquire upon marrying, and what happens when their marriage eventually ends by death or divorce. Couples enter into a written prenuptial agreement to supersede many of the default marital laws that would otherwise apply in the event of divorce, such as the laws that govern the division of property, retirement benefits, savings, and the right to seek alimony (spousal support) with agreed-upon terms that provide certainty and clarify their marital rights.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Good_Friday_Agreement">Good Friday Agreement</a></td>
      <td>The Good Friday Agreement (GFA), or Belfast Agreement (Irish: Comhaontú Aoine an Chéasta or Comhaontú Bhéal Feirste; Ulster-Scots: Guid Friday Greeance or Bilfawst Greeance), is a pair of agreements signed on 10 April 1998 that ended most of the violence of the Troubles, a political conflict in Northern Ireland that had ensued since the late 1960s. It was a major development in the Northern Ireland peace process of the 1990s.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Non-disclosure_agreement">Non-disclosure agreement</a></td>
      <td>A non-disclosure agreement (NDA), also known as a confidentiality agreement (CA), confidential disclosure agreement (CDA), proprietary information agreement (PIA), secrecy agreement (SA), or non-disparagement agreement, is a legal contract or part of a contract between at least two parties that outlines confidential material, knowledge, or information that the parties wish to share with one another for certain purposes, but wish to restrict access to. Doctor–patient confidentiality (physician–patient privilege), attorney–client privilege, priest–penitent privilege and bank–client confidentiality agreements are examples of NDAs, which are often not enshrined in a written contract between the parties.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/TRIPS_Agreement">TRIPS Agreement</a></td>
      <td>The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all the member nations of the World Trade Organization (WTO). It establishes minimum standards for the regulation by national governments of different forms of intellectual property (IP) as applied to nationals of other WTO member nations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Paris_Agreement">Paris Agreement</a></td>
      <td>The Paris Agreement (French: Accord de Paris), often referred to as the Paris Accords or the Paris Climate Accords, is an international treaty on climate change, adopted in 2015. It covers climate change mitigation, adaptation, and finance.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Common_stock">Common stock</a></td>
      <td>Common stock is a form of corporate equity ownership, a type of security. The terms voting share and ordinary share are also used frequently outside of the United States.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Common_stock_dividend">Common stock dividend</a></td>
      <td>A common stock dividend is the dividend paid to common stock owners from the profits of the company.  Like other dividends, the payout is in the form of either cash or stock.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Preferred_stock">Preferred stock</a></td>
      <td>Preferred stock (also called preferred shares, preference shares, or simply preferreds) is a component of share capital that may have any combination of features not possessed by common stock, including properties of both an equity and a debt instrument, and is generally considered a hybrid instrument. Preferred stocks are senior (i.e., higher ranking) to common stock but subordinate to bonds in terms of claim (or rights to their share of the assets of the company, given that such assets are payable to the returnee stock bond) and may have priority over common stock (ordinary shares) in the payment of dividends and upon liquidation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Matthiola_incana">Matthiola incana</a></td>
      <td>Matthiola incana is a species of flowering plant in the cabbage family Brassicaceae. Common names include Brompton stock, common stock, hoary stock, ten-week stock, and gilly-flower.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/New_York_Stock_Exchange">New York Stock Exchange</a></td>
      <td>The New York Stock Exchange (NYSE, nicknamed "The Big Board") is an American stock exchange in the Financial District of Lower Manhattan in New York City. It is by far the world's largest stock exchange by market capitalization of its listed companies at US$30.1 trillion as of February 2018.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Treasury_stock">Treasury stock</a></td>
      <td>A treasury stock or reacquired stock is stock which is bought back by the issuing company, reducing the amount of outstanding stock on the open market ("open market" including insiders' holdings). \nStock repurchases are used as a tax efficient method to put cash into shareholders' hands, rather than paying dividends, in jurisdictions that treat capital gains more favorably.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Convertible_bond">Convertible bond</a></td>
      <td>In finance, a convertible bond or  convertible note or convertible debt (or a convertible debenture if it has a maturity of greater than 10 years) is a type of bond that the holder can convert into a specified number of shares of common stock in the issuing company or cash of equal value.  It is a hybrid security with debt- and equity-like features.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Shareholder">Shareholder</a></td>
      <td>A shareholder (in the United States often referred to as stockholder) of a corporation is an individual or legal entity (such as another corporation, a body politic, a trust or partnership) that is registered by the corporation as the legal owner of shares of the share capital of a public or private corporation. Shareholders may be referred to as members of a corporation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Shareholders'_agreement">Shareholders' agreement</a></td>
      <td>A shareholders' agreement (sometimes referred to in the U.S. as a stockholders' agreement) (SHA) is an agreement amongst the shareholders or members of a company. In practical effect, it is analogous to a partnership agreement.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Annual_general_meeting">Annual general meeting</a></td>
      <td>An annual general meeting (AGM, also known as the annual meeting) is a meeting of the general membership of an organization.\nThese organizations include membership associations and companies with shareholders.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Public_company">Public company</a></td>
      <td>A public company, publicly traded company, publicly held company, publicly listed company, or public limited company is a company whose ownership is organized via shares of stock which are intended to be freely traded on a stock exchange or in over-the-counter markets. A public (publicly traded) company can be listed on a stock exchange (listed company), which facilitates the trade of shares, or not (unlisted public company).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Jessica_Stockholder">Jessica Stockholder</a></td>
      <td>Jessica Stockholder (born 1959) is a Canadian-American artist known for site-specific installation works and sculptures that are often described as "paintings in space." She came to prominence in the early 1990s with monumental works that challenged boundaries between artwork and display environment as well as between pictorial and physical experience. Her art often presents a "barrage" of bold colors, textures and everyday objects, incorporating floors, walls and ceilings and sometimes spilling out of exhibition sites.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Derivative_suit">Derivative suit</a></td>
      <td>A shareholder derivative suit is a lawsuit brought by a shareholder on behalf of a corporation against a third party. Often, the third party is an insider of the corporation, such as an executive officer or director.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Friedman_doctrine">Friedman doctrine</a></td>
      <td>The Friedman doctrine, also called shareholder theory or stockholder theory, is a normative theory of business ethics advanced by economist Milton Friedman which holds that the social responsibility of business is to increase its profits. This shareholder primacy approach views shareholders as the economic engine of the organization and the only group to which the firm is socially responsible.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>HEARUSA INC      Item 1A Risk Factors             This Annual Report on Form 10-K, including the <font color="blue">management</font> discussion     and  analysis  set  out  below,  contains  or <font color="blue">incorporates</font> a number of     forward-looking  statements  within  the meaning of Section 27A of the     <font color="blue">Securities Act </font>of 1933 <font color="blue">and Section </font>21E of the <font color="blue">Securities Act </font>Exchange of     1934</td>
    </tr>
    <tr>
      <td>These forward-looking statements are <font color="blue">based on current <font color="blue">expectations</font></font>,     estimates, forecasts and <font color="blue">projections about</font> the industry and markets in which     we operate and <font color="blue">management</font>’s beliefs and <font color="blue">assumptions</font></td>
    </tr>
    <tr>
      <td>Any statements that are     not statements of historical fact should be considered forward-looking     statements and should be read in <font color="blue">conjunction with</font> our <font color="blue">consolidated financial</font>     statements and notes to the <font color="blue">consolidated financial</font> statements included in     this report as well as the <font color="blue">risk factors set forth</font> below</td>
    </tr>
    <tr>
      <td>The statements are     not  <font color="blue">guarantees</font>  of  future  performance  and  involve  <font color="blue">certain risks</font>,     <font color="blue">uncertainties</font> and <font color="blue">assumptions</font> that are <font color="blue">difficult</font> to predict</td>
    </tr>
    <tr>
      <td>The risks and     <font color="blue">uncertainties</font> described below are not the <font color="blue">only ones facing us</font></td>
    </tr>
    <tr>
      <td><font color="blue">Additional     </font>risks and <font color="blue">uncertainties</font> that we are unaware of <font color="blue">may become important factors</font>     that <font color="blue">affect us</font></td>
    </tr>
    <tr>
      <td>If any of the <font color="blue">following risks</font> occur, our business, financial     condition  and results of <font color="blue"><font color="blue">operations</font> could</font> be <font color="blue">materially</font> and <font color="blue">adversely</font>     affected</td>
    </tr>
    <tr>
      <td>HearUSA has <font color="blue">incurred net losses</font> in <font color="blue">each year since</font> its <font color="blue">organization</font>,     and its <font color="blue">accumulated deficit at</font> <font color="blue">December </font>31, 2005 was dlra103cmam774cmam422</td>
    </tr>
    <tr>
      <td>We expect     quarterly and annual operating results to fluctuate, depending primarily on     the <font color="blue">following factors</font>:         •  Timing of product sales;         •  Level of consumer demand for our products;         •  Timing and success of new centers and acquired centers;         •  Timing and amounts of payments by health insurance and managed care     <font color="blue">organization</font>s</td>
    </tr>
    <tr>
      <td>There can be no assurance that HearUSA will achieve <font color="blue">profitability</font> in     the near or long term or ever</td>
    </tr>
    <tr>
      <td>We may not <font color="blue"><font color="blue">effectively</font> compete</font> in the hearing <font color="blue">care industry</font></td>
    </tr>
    <tr>
      <td>The hearing <font color="blue">care industry</font> is <font color="blue">highly fragmented</font> and barriers to entry     are low</td>
    </tr>
    <tr>
      <td><font color="blue">Approximately </font>11cmam000 practitioners provide testing and dispense     products and services that compete with those sold and <font color="blue">provided by</font> <font color="blue">HearUSA  </font>   We  also  compete  with  small retailers, as well as large networks of     <font color="blue">franchisees</font> and <font color="blue">distributor</font>s established by <font color="blue">larger companies</font>, such as those     <font color="blue">manufacturing</font> and selling Miracle Ear and Beltone products</td>
    </tr>
    <tr>
      <td>Some of the     <font color="blue">larger companies</font> have far <font color="blue">greater resources than</font> HearUSA and could expand     and/or change their <font color="blue">operations</font> to capture the market targeted by <font color="blue">HearUSA  </font>   Large discount retailers, such as Costco Wholesale Corporation, also sell     hearing aids and present a <font color="blue"><font color="blue">competitive</font> threat</font> in our markets</td>
    </tr>
    <tr>
      <td>In addition,     it  is  possible  that  the  hearing  <font color="blue">care market could</font> be <font color="blue">effectively</font>     <font color="blue">consolidated by</font> the <font color="blue">establishment</font> of cooperatives, alliances or <font color="blue">associations</font>     that <font color="blue">could compete</font> more <font color="blue">successfully</font> for the <font color="blue">market targeted by us</font></td>
    </tr>
    <tr>
      <td>10       _________________________________________________________________           We are <font color="blue">dependent on <font color="blue"><font color="blue">manufacturer</font>s</font></font> who may not perform</td>
    </tr>
    <tr>
      <td><font color="blue">HearUSA  </font>is  not  a  hearing <font color="blue">aid <font color="blue">manufacturer</font></font></td>
    </tr>
    <tr>
      <td>We <font color="blue">rely on major</font>     <font color="blue"><font color="blue">manufacturer</font>s</font> to supply our hearing aids and to supply hearing <font color="blue">enhancement</font>     devices</td>
    </tr>
    <tr>
      <td>A  <font color="blue"><font color="blue">significant</font> disruption</font> in <font color="blue">supply from</font> any or all of these     <font color="blue"><font color="blue">manufacturer</font>s</font> could <font color="blue">materially</font> <font color="blue">adversely</font> affect our business</td>
    </tr>
    <tr>
      <td>Our strategic     and <font color="blue">financial relationship with</font> Siemens Hearing Instruments, Inc</td>
    </tr>
    <tr>
      <td>requires     us to <font color="blue">purchase from</font> Siemens a certain portion of our <font color="blue">requirements</font> of hearing     aids at specified prices for a period of <font color="blue">five years</font></td>
    </tr>
    <tr>
      <td><font color="blue">Although Siemens </font>is the     world’s largest <font color="blue">manufacturer</font> of hearing devices, there can be no assurance     that Siemens’ <font color="blue">technology</font> and <font color="blue">product line will remain desirable</font> in the     marketplace</td>
    </tr>
    <tr>
      <td>Furthermore, if Siemens’ <font color="blue">manufacturing</font> capacity cannot keep     pace with the demand <font color="blue">of HearUSA </font>and other customers, our business may be     <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>We  rely  on  <font color="blue">qualified audiologists</font>, without whom our business may be     <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td><font color="blue">HearUSA  </font>currently  employs  <font color="blue">approximately</font> 180 licensed hearing     <font color="blue">professionals</font>,  of whom <font color="blue">approximately</font> 118 are audiologists, 25 are AUD     (Doctors in Audiology) and 37 are licensed hearing aid <font color="blue">specialists</font></td>
    </tr>
    <tr>
      <td>If we     are not able to attract and retain <font color="blue">qualified audiologists</font>, we will be less     able  to  compete  with  networks of hearing <font color="blue">aid retailers</font> or with the     <font color="blue">independent audiologists</font> who also sell hearing aids and our business may be     <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>We  may  not be able to maintain <font color="blue">existing <font color="blue"><font color="blue">agreement</font>s</font></font> or <font color="blue">enter into new</font>     <font color="blue"><font color="blue"><font color="blue">agreement</font>s</font> with health insurance</font> and managed care <font color="blue">organization</font>s, which may     result in <font color="blue">reduced revenues</font></td>
    </tr>
    <tr>
      <td><font color="blue">HearUSA  </font>enters  into provider <font color="blue"><font color="blue"><font color="blue">agreement</font>s</font> with health insurance</font>     companies and managed care <font color="blue">organization</font>s for the furnishing of hearing care     in  exchange for fees</td>
    </tr>
    <tr>
      <td>The terms of most of these <font color="blue"><font color="blue">agreement</font>s</font> are to be     <font color="blue">renegotiated annually</font>, and these <font color="blue"><font color="blue">agreement</font>s</font> may be <font color="blue">terminated by either</font>     party, usually on 90 days or less notice at any time</td>
    </tr>
    <tr>
      <td>There is <font color="blue">no certainty</font>     that we will be able to maintain these <font color="blue"><font color="blue">agreement</font>s</font> on favorable terms or at     all</td>
    </tr>
    <tr>
      <td>If we cannot maintain these <font color="blue">contractual arrangements</font> or <font color="blue">enter into new</font>     arrangements, there will be a material adverse effect on our revenues and     results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>In addition, the <font color="blue">early termination</font> of or failure to     renew  the  <font color="blue"><font color="blue">agreement</font>s</font>  that  provide  for  payment  to  <font color="blue">HearUSA  </font>on a     per-patient-per-month  basis  would cause us to lower our estimates of     revenues to be received over the life of the <font color="blue"><font color="blue">agreement</font>s</font></td>
    </tr>
    <tr>
      <td>This could have a     material adverse effect on our results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> our <font color="blue">joint venture</font> for our <font color="blue">California </font><font color="blue">operations</font> and may not be     able to <font color="blue">attract sufficient patients</font> to our <font color="blue">California </font><font color="blue">centers without</font> it</td>
    </tr>
    <tr>
      <td>HEARx West LLC, our <font color="blue">joint venture</font> with Kaiser Permanente, operates 23     full-service centers in <font color="blue">California </font><font color="blue">as well as two satellite locations</font> in     Kaiser <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>Since their inception, HEARx West centers have derived     <font color="blue">approximately</font> two-thirds of their <font color="blue">revenues from sales</font> to <font color="blue">Kaiser Permanente </font>    members, including <font color="blue">revenues through</font> an <font color="blue"><font color="blue">agreement</font> between</font> the <font color="blue">joint venture</font>     and Kaiser Permanente’s <font color="blue">California </font>division servicing its hearing benefited     <font color="blue">membership</font></td>
    </tr>
    <tr>
      <td>If <font color="blue">Kaiser Permanente </font>does not perform its <font color="blue">obligations under</font> the     <font color="blue">agreement</font>, or if the <font color="blue">agreement</font> is not <font color="blue">renewed upon expiration</font>, the loss of     Kaiser  patients  in the HEARx West <font color="blue">centers would</font> <font color="blue">adversely</font> affect our     business</td>
    </tr>
    <tr>
      <td>In addition, HEARx West <font color="blue">centers would</font> be <font color="blue">adversely</font> affected by the     loss of the ability to market to Kaiser members and promote the business     within  Kaiser’s  <font color="blue">medical centers</font>, including the referral of potential     <font color="blue">customers by</font> Kaiser</td>
    </tr>
    <tr>
      <td>We rely on the efforts and success of <font color="blue">managed care companies</font> that may not be     achieved or sustained</td>
    </tr>
    <tr>
      <td>Many managed care <font color="blue">organization</font>s, including some of those with whom we     have  contracts,  have  experienced  and  are continuing to experience     <font color="blue">significant</font> <font color="blue">difficult</font>ies arising from the <font color="blue">widespread growth</font> and reach of     available plans and benefits</td>
    </tr>
    <tr>
      <td>If the managed care <font color="blue">organization</font>s are unable     to attract and retain covered members in our <font color="blue">geographic markets</font>, we may be     unable to sustain the                                         11       _________________________________________________________________           <font color="blue">operations</font>  of  our centers in those geographic areas</td>
    </tr>
    <tr>
      <td>We will close centers     where warranted and <font color="blue">such closures could</font> have a material adverse effect on     us</td>
    </tr>
    <tr>
      <td>We may not be able to maintain JCAHO <font color="blue">accreditation</font>, and our <font color="blue">revenues may</font>     suffer</td>
    </tr>
    <tr>
      <td>HearUSA has a three-year <font color="blue">accreditation</font> from the <font color="blue">Joint Committee </font>on     Accreditation of Healthcare Organizations (JCAHO) that extends to 2008</td>
    </tr>
    <tr>
      <td><font color="blue">This     </font>status distinguishes HearUSA from other hearing <font color="blue">care providers</font> and is widely     used in our <font color="blue">marketing efforts</font></td>
    </tr>
    <tr>
      <td>If we are not able to maintain our <font color="blue">accredited</font>     status, we will not be able to distinguish HearUSA on this basis and our     <font color="blue">revenues may</font> suffer</td>
    </tr>
    <tr>
      <td>Also, there is no assurance that HearUSA can achieve     JCAHO <font color="blue">accreditation</font> for acquired centers or the network business</td>
    </tr>
    <tr>
      <td>We are exposed to <font color="blue">potential product</font> and <font color="blue">professional liability</font> that could     <font color="blue">adversely</font> <font color="blue">affect us</font> if a successful claim is made in excess of insurance     <font color="blue">policy limits</font></td>
    </tr>
    <tr>
      <td>In the ordinary course of its business, HearUSA may be subject to     product and <font color="blue">professional liability</font> claims alleging that <font color="blue">products sold</font> or     services <font color="blue">provided by</font> the <font color="blue">company failed</font> or had <font color="blue">adverse effects</font></td>
    </tr>
    <tr>
      <td>We maintain     <font color="blue">liability insurance at</font> a <font color="blue">level which</font> we believe to be adequate</td>
    </tr>
    <tr>
      <td>A successful     claim  in excess of the <font color="blue">policy limits</font> of the <font color="blue">liability insurance could</font>     <font color="blue">materially</font> <font color="blue">adversely</font> affect our business</td>
    </tr>
    <tr>
      <td>As the <font color="blue">distributor</font> of products     <font color="blue">manufactured</font> by others, we believe we would properly have <font color="blue">recourse against</font>     the <font color="blue">manufacturer</font> in the event of a <font color="blue">product liability</font> claim</td>
    </tr>
    <tr>
      <td>There can be no     assurance, however, that <font color="blue">recourse against</font> a <font color="blue">manufacturer</font> by HearUSA would be     successful, or that any <font color="blue">manufacturer</font> will maintain <font color="blue">adequate insurance</font> or     otherwise be able to <font color="blue">pay such liability</font></td>
    </tr>
    <tr>
      <td>Risks Relating to HearUSA Common Stock       The price of our <font color="blue">common stock</font> is volatile and <font color="blue">could decline</font></td>
    </tr>
    <tr>
      <td>The price <font color="blue">of HearUSA </font><font color="blue">common stock</font> could fluctuate <font color="blue">significant</font>ly, and     you may be unable to sell your shares at a profit</td>
    </tr>
    <tr>
      <td>There are <font color="blue">significant</font>     price and <font color="blue">volume <font color="blue">fluctuations</font></font> in the <font color="blue">market generally</font> that may be unrelated     to our operating performance, but which nonetheless may <font color="blue">adversely</font> affect the     <font color="blue">market price</font> for HearUSA <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>The price of our <font color="blue">common stock</font> could     change <font color="blue">suddenly due</font> to <font color="blue">factors such as</font>:         •  the amount of our <font color="blue">cash resources</font> and ability to obtain <font color="blue">additional</font>     funding;         •  <font color="blue">economic <font color="blue">conditions</font></font> in markets we are targeting;         •  <font color="blue">fluctuations</font> in operating results;         •  changes in <font color="blue">government regulation</font> of the health<font color="blue">care industry</font>;         •  failure to meet estimates or <font color="blue">expectations</font> of the market; and         •  rate of <font color="blue">acceptance</font> of hearing <font color="blue">aid products</font> in the <font color="blue">geographic markets</font> we     are targeting</td>
    </tr>
    <tr>
      <td>Any of these <font color="blue">conditions</font> may cause the price <font color="blue">of HearUSA </font><font color="blue">common stock</font> to     fall, which may reduce business and <font color="blue">financing <font color="blue">opportunities</font> available</font> to us     and reduce your ability to sell your shares at a profit, or at all</td>
    </tr>
    <tr>
      <td>12       _________________________________________________________________           <font color="blue">HearUSA  </font>might  fail to maintain a listing for its <font color="blue">common stock</font> on the     American  Stock Exchange, making it more <font color="blue">difficult</font> for <font color="blue">stockholders</font> to     dispose of or to obtain accurate <font color="blue">quotations as</font> to the value of their <font color="blue">HearUSA  </font>   stock</td>
    </tr>
    <tr>
      <td><font color="blue">HearUSA  </font><font color="blue">common stock</font> is <font color="blue">presently listed on</font> the American Stock     Exchange</td>
    </tr>
    <tr>
      <td><font color="blue">The American Stock Exchange </font>will consider delisting a company’s     securities if, among other things,         •  the <font color="blue">company fails</font> to maintain stockholder’s equity of at least     dlra2cmam000cmam000 if the company has sustained losses from continuing <font color="blue">operations</font> or     net losses in two of its three most recent fiscal years;         •  the <font color="blue">company fails</font> to maintain stockholder’s equity of dlra4cmam000cmam000 if the     company has sustained losses from continuing <font color="blue">operations</font> or net losses in     three of its <font color="blue">four most recent fiscal years</font>; or         •  the company has sustained losses from continuing <font color="blue">operations</font> or net     losses in its <font color="blue">five most recent fiscal years</font></td>
    </tr>
    <tr>
      <td>HearUSA may not be able to maintain its <font color="blue">listing on</font> the American Stock     Exchange, and there may be no <font color="blue">public market</font> <font color="blue">for <font color="blue">the HearUSA </font></font><font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>In     the event <font color="blue">the HearUSA </font><font color="blue">common stock</font> were <font color="blue">delisted from</font> the American Stock     Exchange, trading, if any, in the <font color="blue">common stock</font> would be conducted in the     over-the-counter  market</td>
    </tr>
    <tr>
      <td>As  a result, you would likely find it more     <font color="blue">difficult</font> to dispose of, or to obtain accurate <font color="blue">quotations as</font> to the market     value of, your HearUSA <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>If “penny stock” <font color="blue">regulations</font> apply to HearUSA <font color="blue">common stock</font>, you may not be     able to sell or dispose of your shares</td>
    </tr>
    <tr>
      <td>If  <font color="blue">HearUSA  </font><font color="blue">common stock</font> were <font color="blue">delisted from</font> the American Stock     Exchange, the “penny stock” <font color="blue">regulations</font> of the Securities and Exchange     <font color="blue">Commission </font> might  apply to <font color="blue"><font color="blue">transaction</font>s</font> in the <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>A “penny     stock” generally includes any over-the-counter equity security that has a     market  price of less than dlra5dtta00 per share</td>
    </tr>
    <tr>
      <td><font color="blue">The <font color="blue">Commission </font></font><font color="blue">regulations</font>     require  the delivery, prior to any <font color="blue">transaction</font> in a penny stock, of a     <font color="blue"><font color="blue">disclosure</font> schedule prescribed by</font> the <font color="blue">Commission </font>relating to the penny     stock</td>
    </tr>
    <tr>
      <td>A broker-dealer effecting <font color="blue"><font color="blue">transaction</font>s</font> in <font color="blue">penny stocks</font> must make     <font color="blue">disclosure</font>s,  including <font color="blue">disclosure</font> of <font color="blue">commissions</font>, and <font color="blue">provide monthly</font>     statements to the <font color="blue">customer with</font> information on the limited market in penny     stocks</td>
    </tr>
    <tr>
      <td>These <font color="blue">requirements</font> may discourage broker-dealers from effecting     <font color="blue"><font color="blue">transaction</font>s</font> in <font color="blue">penny stocks</font></td>
    </tr>
    <tr>
      <td>If the penny stock <font color="blue">regulations</font> were to become     applicable to <font color="blue"><font color="blue">transaction</font>s</font> in shares <font color="blue">of HearUSA </font><font color="blue">common stock</font>, they could     <font color="blue">adversely</font> affect your ability to sell or <font color="blue">otherwise dispose</font> of your shares</td>
    </tr>
    <tr>
      <td><font color="blue">Conversion  </font>of  outstanding HearUSA <font color="blue">convertible subordinated</font> notes and     exercise of outstanding HearUSA options and <font color="blue">warrants could</font> cause substantial     dilution</td>
    </tr>
    <tr>
      <td>As of <font color="blue">December </font>31, 2005, outstanding <font color="blue">convertible subordinated</font> notes,     warrants and options <font color="blue">of HearUSA </font>included:         •  dlra7dtta5 million in <font color="blue">convertible subordinated</font> notes, <font color="blue">convertible into</font>     <font color="blue">approximately</font> 4cmam285cmam715 shares of <font color="blue">common stock</font>, assuming any interest is     paid in cash;         •  Warrants to purchase <font color="blue">approximately</font> 5cmam114cmam853 shares of <font color="blue">common stock</font> and         •  Options to purchase <font color="blue">approximately</font> 5cmam511cmam070 shares of <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>To the extent outstanding subordinated notes are converted, options or     warrants are exercised or <font color="blue">additional</font> shares of capital stock are issued,     <font color="blue">stockholders</font> will incur <font color="blue">additional</font> dilution</td>
    </tr>
    <tr>
      <td>13       _________________________________________________________________           Future sales of <font color="blue">shares may depress</font> the price <font color="blue">of HearUSA </font><font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>If substantial <font color="blue">stockholders</font> <font color="blue">sell shares</font> <font color="blue">of HearUSA </font><font color="blue">common stock</font> into     the <font color="blue">public market</font>, or <font color="blue">investors become concerned</font> that substantial sales     might occur, the <font color="blue">market price</font> <font color="blue">of HearUSA </font><font color="blue">common stock</font> could decrease</td>
    </tr>
    <tr>
      <td>Such a     decrease could make it <font color="blue">difficult</font> for HearUSA to raise capital by selling     stock or to pay for <font color="blue"><font color="blue">acquisition</font>s using stock</font></td>
    </tr>
    <tr>
      <td>In addition, HearUSA employees     hold a <font color="blue">significant</font> number of options to <font color="blue">purchase shares</font>, many of which are     <font color="blue">presently exercisable</font></td>
    </tr>
    <tr>
      <td><font color="blue">Employees </font><font color="blue">may exercise</font> their options and <font color="blue">sell shares</font>     soon after <font color="blue">such options</font> become exercisable, particularly if they need to     raise  funds to pay for the exercise of <font color="blue">such options</font> or to <font color="blue">satisfy tax</font>     <font color="blue">liabilities</font> that they may incur in <font color="blue"><font color="blue">connection with</font> exercising</font> their options</td>
    </tr>
    <tr>
      <td>Because of <font color="blue">the HearUSA </font>rights <font color="blue">agreement</font> and the related rights plan for the     <font color="blue">exchangeable shares</font>, a <font color="blue">third party may</font> be <font color="blue">discouraged from</font> making a takeover     <font color="blue">offer which could</font> be <font color="blue">beneficial</font> to HearUSA and its <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td>HearUSA has <font color="blue">entered into</font> a rights <font color="blue">agreement</font> with The Bank of New York,     as  rights  agent</td>
    </tr>
    <tr>
      <td>issued in     <font color="blue">connection with</font> the <font color="blue">acquisition</font> of Helix</td>
    </tr>
    <tr>
      <td>The rights <font color="blue"><font color="blue">agreement</font>s</font> contain     provisions that <font color="blue">could delay</font> or prevent a <font color="blue">third party from</font> acquiring <font color="blue">HearUSA  </font>   or  replacing  members  of <font color="blue">the HearUSA </font>board of directors, even if the     <font color="blue">acquisition</font> or the <font color="blue">replacements would</font> be <font color="blue">beneficial</font> to HearUSA <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td>The rights <font color="blue"><font color="blue">agreement</font>s</font> could also result in reducing the price that certain     <font color="blue">investors might</font> be willing to pay for shares of the <font color="blue">common stock</font> of <font color="blue">HearUSA  </font>   and  making the <font color="blue">market price</font> lower than it would be without the rights     <font color="blue">agreement</font></td>
    </tr>
    <tr>
      <td><font color="blue">Because HearUSA </font><font color="blue">stockholders</font> do not receive dividends, <font color="blue">stockholders</font> must     <font color="blue">rely on stock <font color="blue">appreciation</font></font> for any return on their <font color="blue">investment</font> in <font color="blue">HearUSA  </font>           We have never declared or <font color="blue">paid cash dividends on</font> any of our capital     stock</td>
    </tr>
    <tr>
      <td>Payment of dividends is restricted pursuant to our <font color="blue">agreement</font> with     Siemens</td>
    </tr>
    <tr>
      <td>We <font color="blue">currently intend</font> to retain any earnings for future growth and,     therefore, do not anticipate <font color="blue">paying cash dividends</font> in the future</td>
    </tr>
    <tr>
      <td>As a     result, only <font color="blue">appreciation</font> of the price <font color="blue">of HearUSA </font><font color="blue">common stock</font> will provide     a return to investors who purchase or acquire <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>Other Risks Relating to the Business of <font color="blue">HearUSA  </font>     We may not be able to <font color="blue">access funds under</font> our credit <font color="blue"><font color="blue">facility</font> with</font> Siemens if     we cannot maintain <font color="blue">compliance with</font> the <font color="blue"><font color="blue">restrictive covenants</font> contained</font>     therein and in our supply <font color="blue">agreement</font> with Siemens</td>
    </tr>
    <tr>
      <td><font color="blue">On February </font>10, 2006, HearUSA and <font color="blue">Siemens Hearing Instruments Inc</font></td>
    </tr>
    <tr>
      <td><font color="blue">entered into</font> an amended and restated credit <font color="blue">agreement</font> pursuant to which     <font color="blue">HearUSA  </font>obtained  a dlra26 million secured credit <font color="blue"><font color="blue">facility</font> from</font> Siemens,     replacing the 2001 credit <font color="blue"><font color="blue">facility</font> extended</font> to the Company by Siemens</td>
    </tr>
    <tr>
      <td>As of     <font color="blue">December </font>31, 2005, an aggregate of dlra23dtta1 million in loans was outstanding     under the credit <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>To continue to access the credit <font color="blue">facility</font>, we are     required to <font color="blue">comply with</font> the terms of the amended credit <font color="blue">facility</font>, including     <font color="blue">compliance with</font> <font color="blue">restrictive covenants</font></td>
    </tr>
    <tr>
      <td>There can be no assurance that we     will be able to <font color="blue">comply with</font> these <font color="blue">restrictive covenants</font> in the future and,     accordingly, may be unable to access the <font color="blue">funds provided under</font> the credit     <font color="blue">facility</font></td>
    </tr>
    <tr>
      <td>If we are unable to <font color="blue">comply with</font> these <font color="blue">restrictive covenants</font>, we     may be found in <font color="blue">default by</font> Siemens and face other penalties under the credit     <font color="blue">agreement</font></td>
    </tr>
    <tr>
      <td>In addition, we have <font color="blue">entered into</font> an amended and <font color="blue">restated supply</font>     <font color="blue">agreement</font> with Siemens, which imposes certain purchase <font color="blue">requirements</font> on us</td>
    </tr>
    <tr>
      <td>If we fail to <font color="blue">comply with</font> the supply <font color="blue">agreement</font>, Siemens may declare us in     default of the credit <font color="blue">agreement</font> and all <font color="blue">loans would</font> be <font color="blue">immediately due</font> and     payable</td>
    </tr>
    <tr>
      <td>14       _________________________________________________________________           We may not be able to obtain <font color="blue">additional</font> capital on <font color="blue">reasonable terms</font>, or at     all, to fund our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>If capital <font color="blue">requirements</font> vary from those currently planned or losses     are <font color="blue">greater than</font> expected, HearUSA may require <font color="blue">additional</font> financing</td>
    </tr>
    <tr>
      <td>If     <font color="blue">additional</font> funds are <font color="blue">raised through</font> the issuance of <font color="blue">convertible debt</font> or     <font color="blue">equity securities</font>, the <font color="blue">percentage ownership</font> of existing <font color="blue">stockholders</font> may be     diluted, the <font color="blue">securities issued may</font> have rights and <font color="blue">preferences senior</font> to     those  of  <font color="blue">stockholders</font>,  and  the  terms of the <font color="blue">securities may impose</font>     <font color="blue">restrictions</font>  on  <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>If  <font color="blue">adequate funds</font> are not <font color="blue">available on</font>     <font color="blue">reasonable terms</font>, or at all, we will be unable to take advantage of future     <font color="blue">opportunities</font> to develop or enhance our business or respond to <font color="blue">competitive</font>     pressures and <font color="blue">possibly even</font> to remain in business</td>
    </tr>
    <tr>
      <td>Future <font color="blue">acquisition</font>s or <font color="blue">investment</font>s could negatively affect our <font color="blue">operations</font>     and  financial  results  or  dilute  the  ownership  percentage of our     <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td>We have initiated a strategic <font color="blue">acquisition</font> program</td>
    </tr>
    <tr>
      <td>We may have to     devote  substantial  time and resources in order to complete potential     <font color="blue">acquisition</font>s</td>
    </tr>
    <tr>
      <td>We may not identify or complete <font color="blue">acquisition</font>s in a timely     manner, on a cost-effective basis, or at all</td>
    </tr>
    <tr>
      <td>Acquired <font color="blue">operations</font> may not be     <font color="blue">effectively</font> integrated into our <font color="blue">operations</font> and may fail</td>
    </tr>
    <tr>
      <td>In the event of any future <font color="blue">acquisition</font>s, HearUSA could:         •  issue <font color="blue">additional</font> stock that <font color="blue">would further dilute</font> our current     <font color="blue">stockholders</font>’ <font color="blue">percentage ownership</font>;         •  incur debt;         •  assume unknown or contingent <font color="blue">liabilities</font>; or          •   experience  <font color="blue">negative effects on</font> reported operating results from     <font color="blue">acquisition</font>-related  charges  and <font color="blue">amortization</font> of acquired <font color="blue">technology</font>,     goodwill and other <font color="blue">intangibles</font></td>
    </tr>
    <tr>
      <td>These <font color="blue"><font color="blue">transaction</font>s</font> involve numerous risks that <font color="blue">could harm</font> operating     results  and cause the price <font color="blue">of HearUSA </font><font color="blue">common stock</font> price to decline,     including:         •  <font color="blue">potential loss</font> of <font color="blue">key employees</font> of acquired <font color="blue">organization</font>s;         •  <font color="blue">problems integrating</font> the acquired business, including its information     systems and personnel;         •  <font color="blue">unanticipated costs</font> that may harm operating results;         •  diversion of <font color="blue">management</font>’s attention from business concerns; and         •  <font color="blue">adverse effects</font> on existing business <font color="blue">relationships with customers</font></td>
    </tr>
    <tr>
      <td>Any of these risks <font color="blue">could harm</font> the business and operating results of     <font color="blue">HearUSA  </font>     Increased exposure to currency <font color="blue">fluctuations</font> could have <font color="blue">adverse effects</font> on     our reported earnings</td>
    </tr>
    <tr>
      <td>Most  of  HearUSA’s  revenues  and  expenses are <font color="blue">denominated</font> in     US dollars</td>
    </tr>
    <tr>
      <td>Some of our revenues and expenses are <font color="blue">denominated</font> <font color="blue">in <font color="blue"><font color="blue">Canadian </font>    </font></font>dollars and, therefore, we are exposed to <font color="blue">fluctuations</font> in the <font color="blue"><font color="blue">Canadian </font>    </font>dollar</td>
    </tr>
    <tr>
      <td>As a result, our earnings will be affected by increases or <font color="blue">decreases</font>     <font color="blue">in the <font color="blue">Canadian </font></font>dollar</td>
    </tr>
    <tr>
      <td><font color="blue">Increases </font>in the value of the <font color="blue">Canadian </font>dollar versus     the US <font color="blue">dollar would tend</font> to increase reported earnings (or reduce losses)     in US <font color="blue">dollar terms</font>, and <font color="blue">decreases</font> in the value of the <font color="blue">Canadian </font>dollar     versus the US <font color="blue">dollar would tend</font> to reduce reported earnings (or increase     losses)</td>
    </tr>
  </tbody>
</table>